National Institutes of Health (NIH)
National Institutes of Health (NIH)
Bethesda, Maryland, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Multi-Institutional Registry for Malignant Peripheral Nerve Sheath Tumors | Malignant Peripheral Nerve Sheath Tumors, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, Neoplasms, Fibrous Tissue, Neoplasms, Nerve Tissue, connective tissue neoplasm, fibrosarcoma, neoplasm, nerve sheath neoplasm, nervous system disorder, neurofibroma, neurofibrosarcoma, neuromuscular disease, peripheral nervous system disorder, peripheral nervous system neoplasm, sarcoma | Recruiting | Not stated | 2026-03-09 | NCT03141021 | |
| Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infections, Primary Immunodeficiency Diseases, hereditary disease, immune system disorder, inborn error of immunity, viral infectious disease | Recruiting | Phase 1 | 2026-01-26 | NCT04691622 | |
| OMEGA: Outcome Measures in Eosinophilic Gastrointestinal Disorders Across the Ages | Digestive System Diseases, Eosinophilia, Eosinophilic enteropathy, Hemic and Lymphatic Diseases, Hypersensitivity, Immediate, digestive system disorder, eosinophilic colitis, eosinophilic esophagitis, eosinophilic gastritis, eosinophilic gastroenteritis, esophageal disorder, esophagitis, gastroenteritis, hematologic disorder, immune system disorder, leukocyte disorder | Recruiting | Not stated | 2025-09-12 | NCT02523118 | |
| Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Active, not recruiting | Phase 1 | 2024-11-08 | NCT03907527 |